Review decisions
Showing 370 results of 633 total
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00664
Product Type: Drug
Control Number: 229313
Manufacturer: Kyowa Kirin, Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2019-07-10
Decision / Authorization Date: 2020-06-16
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00665
Product Type: Drug
Control Number: 230279
Manufacturer: Janssen Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2019-07-31
Decision / Authorization Date: 2020-06-16
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00647
Product Type: Drug
Control Number: 231976
DIN(s): 02498537, 02498545, 02498553, 02498561, 02498588, 02498596, 02498618, 02498626
Manufacturer: Shire Pharma Canada ULC
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2019-09-30
Decision / Authorization Date: 2020-05-01
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00641
Product Type: Drug
Control Number: 227818
Manufacturer: GlaxoSmithKline Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2019-05-16
Decision / Authorization Date: 2020-04-29
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00766
Product Type: Drug
Control Number: 225011
DIN(s): 02498413, 02498421, 02498448, 02498456, 02498464
Manufacturer: Baxter Corporation
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2019-02-27
Decision / Authorization Date: 2020-04-29
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00652
Product Type: Drug
Control Number: 231264
DIN(s): 02498251
Manufacturer: CSL Behring Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2019-09-09
Decision / Authorization Date: 2020-04-22
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00654
Product Type: Drug
Control Number: 226874
DIN(s): 02497867, 02497875
Manufacturer: Takeda Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2019-04-23
Decision / Authorization Date: 2020-04-07
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00649
Product Type: Drug
Control Number: 226905
Manufacturer: Hoffmann-La Roche Ltd.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2019-04-16
Decision / Authorization Date: 2020-04-02
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00645
Product Type: Drug
Control Number: 227240
Manufacturer: AbbVie Corporation
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2019-04-29
Decision / Authorization Date: 2020-03-17
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00629
Product Type: Drug
Control Number: 219213
Manufacturer: Merck Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2018-08-15
Decision / Authorization Date: 2020-03-16